4//SEC Filing
Bellemin Jean-Marc 4
Accession 0001104659-22-071965
CIK 0001425205other
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 5:03 PM ET
Size
9.9 KB
Accession
0001104659-22-071965
Insider Transaction Report
Form 4
Bellemin Jean-Marc
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2022-06-14+18,850→ 18,850 total - Tax Payment
Common Stock
2022-06-14$7.73/sh−9,346$72,245→ 9,504 total - Award
Restricted Stock Units
2022-06-14+18,850→ 18,850 total→ Common stock (18,850 underlying)
Footnotes (7)
- [F1]This is the first vesting of the restricted stock units issued on June 14, 2021.
- [F2]Represents common stock owned by the Reporting Person, excluding common stock purchased pursuant to the Issuer's 2020 Employee Stock Purchase Plan.
- [F3]Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units. This is not an open market sale of securities.
- [F4]Represents common stock remaining after deducting the common stock withheld for taxes.
- [F5]Represents restricted stock units remaining after deducting the vested shares of common stock and common stock withheld for taxes as set forth in Table I above.
- [F6]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F7]Provided the Reporting Person is still employed with the Issuer on December 31, 2022, the remaining restricted stock units shall vest and be settled on such date.
Documents
Issuer
IOVANCE BIOTHERAPEUTICS, INC.
CIK 0001425205
Entity typeother
Related Parties
1- filerCIK 0001754253
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 5:03 PM ET
- Size
- 9.9 KB